Dermapharm

Historical price data

Dermapharm is a mission-driven company focused on providing high-quality, affordable pharmaceutical products, primarily in dermatology and adjacent therapeutic areas. Its key achievements include building a robust portfolio through strategic acquisitions (e.g., Allergopharma, Hübner) and establishing a fully integrated model from development to sales. The company's strategy centers on lifecycle management of established molecules, operational excellence in manufacturing, and leveraging its dual revenue streams from proprietary products and parallel imports for sustainable growth.

Integrated platform for the lifecycle management of established APIs, specializing in formulation development, complex generics, biosimilars, and scalable manufacturing of sterile and non-sterile dosage forms.

Competes with global generics firms (Teva, Sandoz) and European mid-caps (Stada) in branded generics, and with specialists like ALK in allergy immunotherapy. Differentiation stems from integrated manufacturing, a focused sales force, and a 'constellation' model of niche subsidiaries.